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Abstract
Background: Evolution of resistance by target pests is the main threat to the long-term efficacy of crops expressing Bacillus
thuringiensis (Bt) insecticidal proteins. Cry2 proteins play a pivotal role in current Bt spray formulations and transgenic crops
and they complement Cry1A proteins because of their different mode of action. Their presence is critical in the control of
those lepidopteran species, such as Helicoverpa spp., which are not highly susceptible to Cry1A proteins. In Australia, a
transgenic variety of cotton expressing Cry1Ac and Cry2Ab (Bollgard II) comprises at least 80% of the total cotton area. Prior
to the widespread adoption of Bollgard II, the frequency of alleles conferring resistance to Cry2Ab in field populations of
Helicoverpa armigera and Helicoverpa punctigera was significantly higher than anticipated. Colonies established from
survivors of F2 screens against Cry2Ab are highly resistant to this toxin, but susceptible to Cry1Ac.
Methodology/Principal Findings: Bioassays performed with surface-treated artificial diet on neonates of H. armigera and H.
punctigera showed that Cry2Ab resistant insects were cross-resistant to Cry2Ae while susceptible to Cry1Ab. Binding
analyses with
125I-labeled Cry2Ab were performed with brush border membrane vesicles from midguts of Cry2Ab
susceptible and resistant insects. The results of the binding analyses correlated with bioassay data and demonstrated that
resistant insects exhibited greatly reduced binding of Cry2Ab toxin to midgut receptors, whereas no change in
125I-labeled-
Cry1Ac binding was detected. As previously demonstrated for H. armigera, Cry2Ab binding sites in H. punctigera were
shown to be shared by Cry2Ae, which explains why an alteration of the shared binding site would lead to cross-resistance
between the two Cry2A toxins.
Conclusion/Significance: This is the first time that a mechanism of resistance to the Cry2 class of insecticidal proteins has
been reported. Because we found the same mechanism of resistance in multiple strains representing several field
populations, we conclude that target site alteration is the most likely means that field populations evolve resistance to Cry2
proteins in Helicoverpa spp. Our work also confirms the presence in the insect midgut of specific binding sites for this class
of proteins. Characterizing the Cry2 receptors and their mutations that enable resistance could lead to the development of
molecular tools to monitor resistance in the field.
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Introduction
The agronomical impact of bioinsecticides based on Bacillus
thuringiensis (Bt) has increased significantly since the late 1950s
when commercial sprays based on this bacterium were first
developed. Now Bt products are the most successful biopesticides
used in agriculture, forestry and public health [1]. However, the
major current interest of Bt insecticidal proteins (Cry proteins)
resides on the large scale use of insect-resistant engineered plants
expressing these proteins. Such genetically modified Bt-crops
today represent the most widely adopted transgenic crops after
those with herbicide tolerance [2].
Bt-cotton expressing Cry1Ac was first adopted in 1996 in the
US (as Bollgard) and Australia (as Ingard). This Bt-cotton was
developed to target key pests highly susceptible to Cry1Ac, such as
the tobacco budworm, Heliothis virescens, and pink bollworm,
Pectinophora gossypiella, and also to control the less susceptible cotton
bollworms of the Helicoverpa genus (mainly H. zea and H. armigera).
To improve the effectiveness and to delay resistance evolution by
targeted Lepidoptera, a second generation Bt-cotton (Bollgard II)
PLoS ONE | www.plosone.org 1 April 2010 | Volume 5 | Issue 4 | e9975was developed that expressed Cry1Ac and Cry2Ab toxins.
Bollgard II was approved for commercial use in 2002 and
introduced the following year in the US and Australia. Within one
year of the introduction of this variety in Australia, Ingard was
removed from sale to preserve the susceptibility of the major pests
H. armigera and H. punctigera to Cry1Ac [2]. US growers planted
cotton producing only Cry1Ac along with Bollgard II for seven
years (from 2003 to 2009), which may have resulted in an increase
in the LC50’s of populations of H. zea over time that has been
ascribed by Tabashnik et al. 2009 [3] to be due to resistance.
The pyramiding strategy combining different cry genes serves
several purposes: to broaden the insecticidal spectrum, to increase
the effectiveness of the plant for the less susceptible insect species,
and to delay the development of resistance [4–6]. Early studies on
the mode of action of Cry1A and Cry2A proteins [7], along with
the general lack of cross-resistance [reviewed in 5,6], suggested
that they had different targets in the insect midgut. Recently,
independent high affinity binding sites for Cry1Ac and Cry2Ab
were demonstrated in H. armigera and H. zea [8,9]. Consequently,
plant varieties expressing these two toxins should be far more
effective in delaying or even avoiding the evolution of resistance
than a single toxin product [4].
Understanding the mechanism of resistance to Cry2A proteins
is of special interest in the light of the recent reported cases of field-
evolved resistance to Bt-crops expressing Cry1 proteins. Cry1Ab
corn in South Africa failed to control Busseola fusca [10] and the
same occurred for Cry1F corn against Spodoptera frugiperda in Puerto
Rico [11]. Although field failures of Bollgard II plants have not
been reported, results from laboratory diet bioassays estimating
LC50 values suggest that susceptibility of H. zea to Cry1Ac and
Cry2Ab has decreased in the southeastern US [3,12–15].
Regardless of previous exposure to Cry1Ac through spray
formulations and Ingard cotton, resistance monitoring data in
Australian cotton fields suggest that in the major targets H. armigera
and H. punctigera alleles which confer resistance to Cry1Ac were
initially rare [16,17]. This conclusion is based on a large number
of screens performed from 2002 to 2006 of both Helicoverpa spp.
that detected no Cry1Ac resistance alleles (estimated frequency
=0), resulting in upper limits of the estimated frequencies of
0.0003 for H. armigera (n=3304 alleles) and 0.0005 for H. punctigera
(n=2180 alleles). Surprisingly, prior to the widespread adoption of
Bollgard II in 2004/2005, a relatively high frequency of recessive
alleles for Cry2Ab resistance was found in both Helicoverpa species
using F2 screens (0.0018–0.0033) [16,17].
Laboratory selected insects have provided evidence for several
mechanisms of resistance to Cry proteins, though altered binding to
midgut receptors is the most common one to confer high levels of
resistance to Cry1A proteins [5,6]. It is noteworthy that, without
exception, this mechanism of resistance to Cry1A proteins has been
the major one found in insect populations that have developed
resistance to Bt commercial formulations under field or semi-field
(greenhouse) conditions [18–25]. Sofar, the mechanismof resistance
has not been studied yet in those cases of field-evolved resistance to
Bt crops. Despite the key role that Cry2Ab is currently playing and is
likely to play in future insect-resistant crops, few studies have dealt
with resistance to Cry2 proteins and nothing is known about the
possible underlying biochemical and/or physiological mechanisms
of resistance to this class [5,6].
In this article we present results on the characterization of the
field-isolated resistance to Cry2Ab in H. armigera and H. punctigera.
We previously demonstrated for both species that these Cry2Ab
resistant insects are susceptible to Cry1Ac [26,27], and for H.
armigera that Cry2Ab resistant insects are cross-resistant to Cry2Aa
[26]. Herein we report results from additional bioassays with
Cry1Ab and Cry2Ae, as well as analyses to determine whether
Cry2Ab binding was reduced in the field-isolated resistant insects
and if the occurrence of shared binding sites could account for the
cross-resistance patterns that we observed.
Results
Susceptibility assays
Surface treatment bioassays performed on neonates of Cry2Ab
resistant H. armigera and H. punctigera showed that these strains were
completely resistant to the maximum concentration of Cry2Ab
employed (Table 1). Mortality at the maximum concentration was
low for the H. armigera resistant strain SP15 (overall, 5%) and for
the H. punctigera resistant strain Hp4-13 (6%), and in both species
was similar to that in the control treatment. Furthermore, the
Cry2Ab resistant strains of both species were similarly resistant to
Cry2Ae (Table 1). It had been demonstrated previously that SP15
was cross-resistant to Cry2Aa [26]. Insects from all strains tested
were susceptible to Cry1Ab and Cry1Ac (Table 1) [27,28]. In
previous work the H. armigera strain 6–364 strain was found to be
allelic to SP15 in complementation tests [29] and when isolated
from F2 screens was fully susceptible to Cry1Ac.
Binding of
125I-Cry proteins to brush border membrane
vesicles (BBMV) from H. armigera
To determine whether reduced binding of Cry2A proteins could
be the underlying mechanism of Cry2Ab resistance in the H.
Table 1. Bioassays with Cry2Ab resistant and susceptible H.
armigera and H. punctigera.
Species Strain Toxin LC50
a(95% CI) Slope 6 SE
H. armigera GR susceptible Cry1Ab 0.17 (0.09–0.34) 1.14 6 0.13
Cry1Ac
b 0.011 (0.01–0.02) 1.23 6 0.12
Cry2Ab 0.13 (0.09–0.18) 1.81 6 0.22
Cry2Ae 0.13 (0.10–0.18) 1.80 6 0.20
ANGR susceptible Cry1Ab 0.13 (0.11–0.16) 1.82 6 0.17
Cry1Ac
c 0.07 (0.05–0.09) 1.7 6 0.1
Cry2Ab 0.06 (0.04–0.07) 2.6 6 0.27
Cry2Ae 0.06 (0.05–0.08) 2.02 6 0.19
SP15 resistant Cry1Ab 0.09 (0.06–0.12) 2.07 6 0.16
Cry1Ac
b 0.02 (0.01–0.02) 1.23 6 0.12
Cry2Ab .250
d -
Cry2Ae .250
d -
H. punctigera LHP susceptible Cry1Ab 0.73 (0.46–1.42) 1.10 6 0.14
Cry1Ac
e 0.12 (0.08–0.21) 1.00 6 0.11
Cry2Ab 0.06 (0.04–0.10) 1.42 6 0.13
Cry2Ae 0.08 (0.05–0.10) 1.77 6 0.19
Hp4.13 resistant Cry1Ab 0.24 (0.14–0.37) 1.75 6 0.17
Cry1Ac
e 0.19 (0.15–0.26) 2.01 6 0.25
Cry2Ab .250
d -
Cry2Ae .250
d -
aValues are in mg/cm
2.
bData from [26].
cData from [28].
dLC50 and slopes could not be calculated as there was little or no mortality at
the maximum concentration tested (0.25 mg/cm
2).
eData from [27].
doi:10.1371/journal.pone.0009975.t001
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with
125I and specific binding to BBMV from susceptible (GR and
ANGR) and resistant (SP15 and 6–364) H. armigera strains was
tested.
As a first approach, binding of Cry2Ab was tested by incubating
BBMV from the GR strain with radiolabeled Cry2Ab (Fig. 1A).
An expected band of 49 kDa was observed [9], corresponding to
the binding of
125I-Cry2Ab to BBMV from susceptible insects
(Fig. 1A, lane 2). Co-incubation with an excess of unlabeled
Cry2Ab reduced binding of
125I-Cry2Ab (Fig. 1A, lane 3),
indicating that most of this binding was specific. However for
BBMV from the resistant SP15 strain,
125I-Cry2Ab failed to bind
(Fig. 1A, lane 4). This result demonstrates that specific binding
sites for Cry2Ab are altered in resistant insects.
In a second approach, a fixed concentration of labeled protein
was incubated with increasing concentrations of BBMV from each
strain (Fig. 2). Non-specific binding was determined by adding an
excess of unlabeled protein and specific binding was calculated by
subtracting the non-specific binding from the total binding. In the
two susceptible strains, an increase in the specific binding of
125I-
Cry2Ab was observed corresponding to the increase of BBMV
concentration (Fig. 2A and 2B). In contrast, in the two resistant
strains, specific binding of Cry2Ab was either totally absent or
highly reduced (Fig. 2A and 2B). In the case of
125I-Cry1Ac, the
specific binding was not substantially different for the susceptible
and resistant strains at increasing concentrations of BBMV
(Fig. 2C). These results indicate that resistance to Cry2Ab is due
to the lack of specific high affinity binding sites for Cry2Ab in the
midgut. Binding of Cry1Ac in the resistant insects remains
unaltered, confirming that Cry1Ac binding sites are not shared
with those of Cry2Ab. This is in agreement with the lack of cross-
resistance between these two proteins (Table 1) and the binding
site model for this species [8,9].
Binding of
125I-Cry proteins to BBMV from H. punctigera
strains
Similar binding experiments as described for H. armigera above
were carried out with a susceptible (LHP) and a Cry2Ab resistant
(Hp4-13) strain of H. punctigera. Qualitative experiments with
125I-
Cry2Ab showed binding of this protein to BBMV from susceptible
larvae (Fig. 1B, lane 1) that was displaced by unlabeled Cry2Ab
(Fig. 1B, lane 2). Absence of
125I-Cry2Ab binding was observed in
resistant insects (Fig. 1B, lane 3). When binding of
125I-Cry2Ab
was measured at increasing concentrations of BBMV, specific
binding increased in the susceptible strain in a dose dependent
manner, however, a very strong reduction in binding was observed
with BBMV from the resistant strain (Fig. 3A). No marked
differences in binding were found for
125I-Cry1Ac between
resistant and susceptible strains (Fig. 3B). These results, like those
for H. armigera, show that an alteration in Cry2Ab binding is
responsible for the resistance to this protein and that Cry2Ab
binding sites are different from Cry1Ac sites, which remain
unaltered in the resistant insects. The pattern of binding or lack of
binding is in agreement with the susceptibility pattern shown in
Table 1.
Competition experiments with H. punctigera BBMV
To unravel the binding site specificity of the Cry proteins under
study in H. punctigera, binding of
125I-Cry2Ab and
125I-Cry1Ac was
measured in the presence of unlabeled Cry proteins as
competitors.
Homologous competition assays using
125I-Cry2Ab (and
unlabeled Cry2Ab) confirmed that this protein binds saturably to
H. punctigera BBMV (Fig. 4A). Binding parameters determined
from this experiment showed that binding was of high affinity
(Kd=6.561.6 nM) with an Rt value of 2.160.4 pmol per mg of
BBMV (Table 2). Competition binding assays using Cry2Ae as a
heterologous competitor showed that this protein readily compet-
ed with
125I-Cry2Ab (Fig. 4A). In contrast, unlabeled Cry1Ac was
unable to compete for
125I-Cry2Ab binding in the range of
concentrations tested. These results indicate that Cry2Ab binding
sites are shared with Cry2Ae, but not with Cry1Ac.
Competition assays were also carried out with
125I-Cry1Ac
using Cry1Ac, Cry2Ab and Cry2Ae as competitors (Fig. 4B).
Binding parameters obtained from homologous competition
experiments are given in Table 2. Cry2A proteins did not
compete for binding with
125I-Cry1Ac, confirming the occurrence
of different binding sites for Cry1Ac and Cry2A proteins in this
insect species, and in agreement with the susceptibility pattern
observed in the resistant insects.
Discussion
Since reduced binding is a major mechanism of resistance to
Cry1A proteins [5,6], and because the occurrence of Cry2A
specific binding sites has been recently established in H. armigera
and H. zea [8,9], we wanted to assess whether altered Cry2Ab
binding would explain the field-isolated Cry2Ab resistance.
BBMV prepared from H. armigera and H. punctigera resistant insect
larvae had essentially lost the capacity to bind Cry2Ab, but could
readily bind Cry1Ac. These results indicate that an alteration in
the Cry2A receptor/s is responsible for conferring resistance to
these proteins and that non-specific or non-saturable binding of
Cry2A to the insect midgut is not involved in toxicity of Cry2A
proteins as earlier proposed [7]. Since Cry2Ab and Cry2Ae, but
not Cry1Ac, share binding sites in both Helicoverpa species, the
alteration of the receptor for Cry2A proteins is expected to confer
resistance simultaneously to these two proteins without affecting
Figure 1. Binding of
125I-Cry2Ab proteins to BBMV from
Helicoverpa spp. revealed by autoradiography.
125I-Cry2Ab was
incubated with BBMV in the absence or the presence of an excess of
competitor, and the pellet obtained after centrifuging the reaction
mixture was subjected to SDS-PAGE and exposed to an X-ray film for 10
days. (A)
125I-Cry2Ab binding to H. armigera: lane 1, a sample of
125I-
Cry2Ab protein used in the binding assays; lane 2,
125I-Cry2Ab
incubated with BBMV in the absence of competitor; lane 3, homologous
competition (excess of unlabeled Cry2Ab); lane 4,
125I-Cry2Ab incubated
with BBMV from SP15-resistant insects. (B)
125I-Cry2Ab binding to H.
punctigera: lane 1,
125I-Cry2Ab incubated with BBMV in the absence of
competitor; lane 2, homologous competition; lane 3,
125I-Cry2Ab
incubated with BBMV from Hp4-13-resistant insects; lane 4, a sample
of the
125I-Cry2Ab protein used in the binding assays.
doi:10.1371/journal.pone.0009975.g001
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with the bioassay data in Table 1. It should be mentioned that,
although a large percentage of Cry2Ab binding in experiments
presented herein seems to be non-specific, it is very likely that most
of the radioactivity catalogued as non-specific binding is actually
radioactivity coming from precipitated labeled-Cry2Ab [9].
Our results with field isolated resistance differ from other studies
which dealt with cross-resistance between Cry1A and Cry2A
proteins in laboratory selected strains. Laboratory selection of a H.
virescens strain with Cry1Ac conferred moderate levels of resistance
to Cry2Aa and to a number of Cry1 proteins, and the inheritance
of resistance appeared to be polygenic [30,31]. In a study
Figure 2. Binding of
125I-Cry proteins to BBMV from H. armigera.
Binding of iodinated Cry proteins to H. armigera at increasing
concentrations of BBMV from GR (N) and ANGR (&) susceptible strains,
and to SP15 (#) and 6-364 (%) resistant strains. Non-specific binding
was determined by adding an excess of unlabeled protein to the
reaction. Specific binding was calculated by subtracting the non-
specific binding from the total binding. (A) Specific binding of
125I-
Cry2Ab to BBMV from SP15 and its susceptible control (GR) strain. (B)
Specific binding of
125I-Cry2Ab to BBMV from 6-364 and its susceptible
control (ANGR) strain. (C) Specific binding of
125I-Cry1Ac. Data points in
figures A and B represent the means of two replicates.
doi:10.1371/journal.pone.0009975.g002
Figure 3. Binding of
125I-Cry proteins to BBMV from H.
punctigera. Binding of iodinated Cry proteins to H. punctigera at
increasing concentrations of BBMV from the susceptible LHP strain (N)
and the resistant Hp4-13 strain (%). Non-specific binding was
determined by adding an excess of unlabeled protein to the reaction.
Specific binding was calculated by subtracting the non-specific binding
from the total binding. (A) Specific binding of
125I-Cry2Ab. (B) Specific
binding of
125I-Cry1Ac. Data points in figure A represent the means of
two replicates.
doi:10.1371/journal.pone.0009975.g003
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tolerance to Cry2Ab were found in insects collected from Cry1Ac-
cotton fields; tolerance to Cry1Ac and Cry2Ab was positively
correlated and it was suggested to represent the cumulative effect
of multiple minor resistance genes [32]. Just as low-level broad-
spectrum resistance is typical of the additive effects of multiple loci,
high-level narrow-spectrum resistance suggests the involvement of
major genes, as seems to be the case in the field derived resistant
populations studied herein. Recently, resistance to Cry1Ac and
Cry2Ab was obtained upon laboratory selection with Cry2Ab of a
Pectinophora gossypiella population already carrying Cry1Ac resis-
tance alleles; based on the high levels of resistance and previous
data on the mode of action of the two proteins, the dual resistance
was probably due to the combined action of resistance alleles at
two independent loci [33,34].
A key step in the mode of action of Bt insecticidal Cry proteins is
the binding to specific sites in the brush border membrane of the
larval midgut [35,36]. Significantly reduced binding of insecticidal
proteins from the Cry1A family has been found in several insect
species selected for resistance to Bt: Plodia interpunctella [37,38],
Plutella xylostella [18–23,25], H. virescens [31,39], P. gossypiella [33],
H. armigera [40], and Trichoplusia ni [24]. This type of altered target
site mechanism has not been previously shown for other Cry
proteins, although it has indirectly been proposed for Cry1F and
Cry1J in P. xylostella [23,41] and H. virescens [42]. In some, but not
in all cases, the lack of binding has been shown to be linked with
mutations in a cadherin gene [43–46].
The recent demonstration that Cry2A toxins bind to specific
sites located in the brush border of the midgut of H. armigera [8,9]
and H. zea [9] also showed that these sites were different from
those of Cry1A proteins. Herein we extended these data with a
new species, H. punctigera, and show that, like H. armigera: (i)
Cry2Ab binds saturably and with high affinity to sites in the brush
border membrane, (ii) Cry2Ae competes for the same binding
sites, and (iii) these sites are not recognized by Cry1Ac, which has
independent high affinity binding sites. This pattern of binding
sites predicts that resistance to one class of Cry proteins (i.e.,
Cry1A) can occur without affecting the other class (i.e., Cry2A)
and vice versa. These results, along with the demonstration that
binding can be lost to one class of toxins (e.g., Cry2A) without
affecting binding to the other class (e.g., Cry1A) strongly supports
the strategy of pyramiding cry1A and cry2A genes in transgenic
plants.
Our results show that binding site alteration, as a mechanism of
resistance, is not restricted to the Cry1A class of proteins, but can
also extend to the Cry2A class. Because we examined multiple
Cry2A-resistant strains carrying resistance alleles present in field
populations, we conclude that binding site alteration is the most
likely means that field populations evolve resistance to Cry2
proteins in Helicoverpa spp. Based on the present and previous
studies, it is likely that changes in midgut binding sites will prove to
be the most common means that insects evolve field resistance to
Bt insecticidal proteins.
The confirmation of the presence in the insect midgut of specific
binding sites for the Cry2A class of proteins leads to the interest to
characterize the receptors in the light of developing molecular
tools for monitoring the evolution of resistance in the field (e.g.,
[47,48]).
Materials and Methods
Insect strains
The Cry2Ab resistant strains SP15, 6–364 (H. armigera) and
Hp4-13 (H. punctigera) were isolated from Australian field
populations using an F2 screen in 2002, 2006 and 2004,
respectively. Each resistant strain was established from a single
pair of moths. Progeny from the pair were allowed to mate
together and the colony was formed from F2 offspring that
survived a discriminating concentration of Cry2Ab. Details of the
proceedures and toxin used to establish resistant H. armigera and H.
punctigera strains and the origin of susceptible strains are presented
in Mahon et al. [16] and Downes et al. [17].
The resistant strains examined are typical of similar field isolates
of both species in which resistance is due to alleles at the same
locus [29, Downes et al., unpublished]. Resistance is recessive and
Figure 4. Competition binding experiments with H. punctigera
BBMV. Binding of
125I-Cry2Ab (A) and
125I-Cry1Ac (B) to BBMVs from H.
punctigera at increasing concentrations of unlabeled competitor:
Cry2Ab (N), Cry2Ae (#), and Cry1Ac (%).
doi:10.1371/journal.pone.0009975.g004
Table 2. Binding parameters in H. punctigera
a.
Toxin Kd (nM) Rt (pmol/mg)
b
Cry1Ac 0.75 6 0.10 11.6 6 1.0
Cry2Ab 6.5 6 1.6 2.1 6 0.4
aMean 6 SEM.
bValues are expressed in picomoles per milligram of BBMV protein.
doi:10.1371/journal.pone.0009975.t002
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Cry2Ab toxin [26,27].
The GR and ANGR strains (H. armigera) and LHP (H. punctigera)
are susceptible to Cry1Ac and Cry2Ab toxins [26,27, see also
below]. This susceptibility is monitored regularly, including prior
to the experiments reported herein, by evaluating responses to
discriminating doses of these toxins that kill ,95% of susceptible
neonate larvae.
Since the resistant strains established from the F2 screen initially
possessed a very restricted gene pool they were crossed to the
susceptible strains, maintained without selection for one genera-
tion, and re-selected with Cry2Ab. The SP15, 6–364, and Hp4-13
resistant strains had been outcrossed seven (to GR), four (to
ANGR), and five (to LHP) times, respectively. This method
maintained fitness in the resistant strains and produced a colony
that was presumed to be near isogenic with the corresponding
susceptible strain.
Bioassays
Surface contamination bioassays were performed with Cry2Ab
resistant and susceptible neonates using methods outlined in
Mahon et al. [26]. At least three replicate assays were performed
for each toxin and strain evaluated. Each assay assessed the
response of 22–45 insects to the toxin at each concentration. For
each assay, diet presented to a similar number of neonates
remained untreated to assess control mortality. Analyses were
conducted using Polo Plus [49]. Data presented represent the
combined data from replicates.
B. thuringiensis Cry proteins. The Cry1Ab, Cry1Ac,
Cry2Ab, and Cry2Ae were obtained from recombinant E. coli
strain WK6 harbouring plasmid pMAAB expressing Cry1Ab [50],
B. thuringiensis strain HD73 (Bacillus Genetic Stock Collection,
Columbus, OH), recombinant B. thuringiensis strain BtIPS78/11
[51] and recombinant B. thuringiensis subsp. berliner 1715 Cry
2
mutant (Institut Pasteur, Paris) harbouring plasmid pGA32
expressing Cry2Ae, respectively, as previously described [9].
Midgut isolation and BBMVs preparation
Last instar larvae of H. armigera and H. punctigera were dissected
and the midguts lyophilized. BBMV were prepared from
lyophilized midguts [52] by the differential magnesium precipita-
tion method [53], frozen in liquid nitrogen and stored at 280uC.
The protein concentration of the BBMV preparations was
determined by the method of Bradford [54] using bovine serum
albumin as a standard.
Radiolabeling of Cry proteins
Cry1Ac and Cry2Ab proteins were labeled using the chlora-
mine T method as previously described [9,55]. The purity of the
labeled proteins were checked by analyzing the elution fractions by
SDS-PAGE with further exposure at 220uC of the dry gel to an
X-ray film.
Binding assays with
125I-labeled Cry1Ac and Cry2Ab
Prior to being used, BBMV were centrifuged for 10 min at
16000 6g and resuspended in binding buffer (8 mM Na2HPO4,
2m MK H 2PO4, 150 mM NaCl; pH 7.4; 0.1% bovine serum
albumin).
To check the presence of specific binding and determine the
optimal concentration of BBMV to use in competition experi-
ments, increasing amounts of BBMV were incubated with either
0.28 nM or 0.04 nM of labeled Cry1Ac and Cry2Ab, respectively,
in a final volume of 0.1 ml of binding buffer for 1 h at 25uC. An
excess of unlabeled toxin (0.4 mM) was used to calculate the non-
specific binding. After incubation, samples were centrifuged at
16000 6 g for 10 min and the pellet was washed with 500 mlo f
cold binding buffer. The radioactivity retained in the pellet was
measured in an LKB 1282 Compugamma CS gamma counter.
Specific binding was calculated by subtracting the non-specific
binding from the total binding.
Competition experiments were done by incubating either
20 mg of BBMV and 0.28 nM
125I-Cry2Ab, or 5 mgo fB B M V
and 0.04 nM
125I-Cry1Ac, in a final volume of 0.1 ml of
binding buffer for 1 h at 25uC in the presence of increasing
amounts of unlabeled Cry proteins. The reaction was stopped
by centrifugation as described above. For quantitative assays,
the fraction of labeled protein bound to BBMV was determined
in a gamma counter. Dissociation constants and concentration
of binding sites were calculated using the LIGAND program
[56]. For qualitative assays, the pellets were boiled for 10 min in
l o a d i n gb u f f e ra n dr u ni nS D S - P A G E .T h el a b e l e dp r o t e i n
retained in the pellet was detected by autoradiography after 10
days of exposure at 220uC.
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